Simon Fraser University announced on March 3, 2020 that researchers in its Brinkman Laboratory have collaborated with U.S. researchers to analyze a new drug that can kill a wide range of superbugs. (Simon Fraser University photo)

Human trials underway after B.C. researchers analyze effects of new ‘superbug-killing compound’

Brinkman Lab in Burnaby helped analyze effects of new drug after University of Cincinnati discovery

Researchers at Simon Fraser University’s Brinkman Lab in Burnaby participated in a landmark study that tests how a new drug can kill a range of superbugs – including some bacteria now resistant to all common antibiotics.

According to a March 3 release, researchers at the University of Cincinnati discovered two inexpensive chemicals work to kill disease-causing bacteria more effectively when combined.

The U.S. researchers combined the chemicals — ethylenediaminetetraacetic acid and acidified nitrite — to create the new drug known as AB569.

ALSO READ: B.C. widow sues health authority after ‘untreatable’ superbug killed husband

SFU researchers then used computers to analyze data from bacteria treated with the new drug. The results from the study indicated the drug can kill pathogens identified by the World Health Organization as urgently requiring new treatments, and posing the greatest threat to human health.

For example, the top three “priority pathogens” include Pseudomonas aeruginosa, a type of bacteria that can cause infections in the lungs, urinary tract, or blood that is known as the leading cause of morbidity in patients with cystic fibrosis.

Erin Gill, a PhD researcher at the University of British Columbia during the study and now at the Brinkman Lab, was involved in the analysis. She told Black Press Media by phone that it was inspiring to be part of “such a large, collaborative project.”

“It’s really important work to be able to contribute to the discovery of potentially novel drugs that can help to kill bacteria, because we’re running out of them,” Gill said.

The lab’s lead database developer Geoff Winsor agreed.

“We have a growing crisis with antibiotics becoming less and less effective, and treatments are failing,” Winsor said. “That’s why it’s important to test and develop new drugs and approaches to treat disease-causing bacteria that are highly resistant to existing antibiotics.”

The new drug is currently in the first phase of human trials that are being managed by Toronto-based biotechnology firm Arch Biopartners.

“I think they’re going to have some results from that soon,” Winsor said.

ALSO READ: SFU reviewing security measures after data breach exposes personal information

Correction: This story has been updated. The University of Cincinnati was responsible for testing the new AB569 drug, not the SFU Brinkman Lab.



karissa.gall@blackpress.ca

Like us on Facebook and follow us on Twitter

SFU

Get local stories you won't find anywhere else right to your inbox.
Sign up here

Just Posted

Central Abbotsford apartment to proceed to a public hearing – eventually

Six-storey apartment building would have extensive rooftop recreation area

Total Makeover Challenge moves to voting for Top 5 finalists

Online voting for Abbotsford challengers runs April 9 to 14

VIDEO: Abbotsford’s Sandy Hill Elementary hosts car parade for students

Local school lets students know how much they miss them as COVID-19 delays classes

Character Abbotsford Conference postponed until 2021

Fourth conference was originally planned to occur later this year

Price tag grows for first phase of Fraser Highway expansion in Abbotsford

Projected cost of first phase rises from $7 million to $9.3 million

COVID-19: Trudeau says 30K ventilators on the way; 3.6M Canadians claim benefits

Canada has seen more than 17,000 cases and at least 345 deaths due to COVID-19

Logan Boulet Effect: Green Shirt Day calls on Canadians to become organ donors

While social distancing, the day also honours the 16 lives lost in the 2018 Humboldt Broncos Crash

COMMENTARY: Knowing where COVID-19 cases are does not protect you

Dr. Bonnie Henry explains why B.C. withholds community names

As Canadians return home amid pandemic, border crossings dip to just 5% of usual traffic

Non-commercial land crossing dipped by 95%, air travel dropped by 96 per cent, according to the CBSA

B.C. wide burning restrictions come into effect April 16

‘Larger open burns pose an unnecessary risk and could detract from wildfire detection’

B.C. secures motel, hotel rooms for COVID-19 shelter space

Community centres, rooms reserved for pandemic self-isolation

Look at hospitalizations, not recovery stats for COVID-19, B.C. professor says

Cases in hospital are a definitive count of people who have the novel coronavirus

B.C. First Nations want to launch fight of Trans Mountain pipeline approval

Last month, the Supreme Court of Canada decided not to hear five challenges about the pipeline

Most Read